We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

83 hedge funds and large institutions have $152M invested in BioSpecifics Technologies Corp. in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

56% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 25

37% more capital invested

Capital invested by funds: $111M → $152M (+$41.5M)

5% more funds holding

Funds holding: 79 → 83 (+4)

Holders
83
Holders Change
+4
Holders Change %
+5.06%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
39
Reduced
25
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCMC
RK Capital Management (Colorado)
Colorado
+$5M
2
JAM
JW Asset Management
Florida
+$2.62M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.12M
4
BFA
BlackRock Fund Advisors
California
+$1M
5
Invesco
Invesco
Georgia
+$802K

Top Sellers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
-$3.28M
2
NI
Numeric Investors
Massachusetts
-$2.7M
3
EI
EAM Investors
California
-$1.55M
4
BA
BlackRock Advisors
Delaware
-$1.3M
5
RFC
Russell Frank Company
Washington
-$667K
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$2.19M -$1.55M -36,367 -46%
Charles Schwab
27
Charles Schwab
California
$2.17M -$316K -7,405 -15%
Morgan Stanley
28
Morgan Stanley
New York
$2.01M +$119K +2,785 +8%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.81M +$61.3K +1,438 +4%
PI
30
Putnam Investments
Massachusetts
$1.79M -$11.9K -279 -0.8%
Goldman Sachs
31
Goldman Sachs
New York
$1.75M – – –
BA
32
BlackRock Advisors
Delaware
$1.6M -$1.3M -30,497 -50%
Two Sigma Investments
33
Two Sigma Investments
New York
$1.51M +$410K +9,618 +49%
AQR Capital Management
34
AQR Capital Management
Connecticut
$1.5M +$791K +18,552 +177%
BCM
35
Bridgeway Capital Management
Texas
$1.46M -$17.1K -400 -1%
TCIM
36
TIAA CREF Investment Management
New York
$1.45M +$110K +2,586 +10%
GA
37
Geneva Advisors
Illinois
$1.45M +$301K +7,048 +34%
RFC
38
Russell Frank Company
Washington
$1.38M -$667K -15,643 -37%
American Century Companies
39
American Century Companies
Missouri
$1.33M +$5.59K +131 +0.5%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.24M +$153K +3,600 +18%
TAM
41
Tocqueville Asset Management
New York
$1.03M -$213K -5,000 -20%
BIM
42
BlackRock Investment Management
Delaware
$903K +$282K +6,608 +61%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$865K – – –
ACM
44
Ativo Capital Management
Illinois
$613K -$106K -2,483 -19%
BG
45
BlackRock Group
United Kingdom
$585K -$74.1K -1,737 -13%
CCM
46
Cadence Capital Management
Massachusetts
$550K +$455K +10,660 New
Ameriprise
47
Ameriprise
Minnesota
$515K +$83.2K +1,952 +24%
Prudential Financial
48
Prudential Financial
New Jersey
$501K +$414K +9,700 New
NA
49
Navellier & Associates
Nevada
$496K -$15.7K -369 -4%
Citadel Advisors
50
Citadel Advisors
Florida
$484K -$168K -3,936 -30%
1
2
3 4

BSTC Hedge Fund Activity: Q2 2015 in Review

83 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2015, worth a combined $152M — up 37% from $111M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BSTC positions and 5 closed out — a net gain of 4 holders — while 39 added to existing stakes and 25 trimmed.

The largest buyer was RK Capital Management (Colorado), opening a new position worth an estimated $5M. The largest seller was Northpointe Capital, cutting an estimated $3.28M.

  • 83 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2015, up from 79 in Q1 2015.
  • Funds reported $152M of BioSpecifics Technologies Corp. stock for Q2 2015, up 37% quarter-over-quarter.
  • 9 funds opened new BioSpecifics Technologies Corp. positions in Q2 2015 and 5 closed out, a net change of +4 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2015 was RK Capital Management (Colorado), an estimated $5M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2015 was Northpointe Capital, an estimated $3.28M sold.

Based on aggregated 13F filings for Q2 2015.